RxDoctor Payments DataLook up a doctor →

Saurabh Mangalik, MD

Internal Medicine · Denver, CONPI 1801971486

Payments from drug & device makers

$14,217in general payments, 2019–2025

Across 686 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Novo Nordisk$914
  • Astellas Pharma US Inc$768
  • GSK$756
  • plus $6K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)118$2,619
AstraZeneca(2 entities)74$1,841
Lilly USA, LLC76$1,451
Novo Nordisk53$914
Astellas Pharma US Inc26$768
GSK37$756
Pfizer34$630
Amgen(2 entities)29$564
Bayer17$531
Johnson & Johnson26$411
Novartis15$395
Esperion Therapeutics, Inc.20$377
Boehringer Ingelheim17$318
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC19$280
Gilead6$238
Merck15$225
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)11$206
Kowa Pharmaceuticals America, Inc.10$159
Amarin Pharma, Inc.8$145
Exact Sciences6$132
Amneal Pharmaceuticals LLC6$103
Idorsia Pharmaceuticals US Inc6$101
Grifols USA, LLC5$98
Sumitomo Pharma America, Inc.4$82
IBSA Pharma Inc.4$61
Nestle Healthcare Nutrition Inc.3$59
Neuronetics, Inc.3$57
Teva Pharmaceuticals USA, Inc.3$50
E.r. Squibb & Sons, L.L.C.3$49
Ultragenyx Pharmaceutical Inc.3$49
Jazz Pharmaceuticals Inc.2$44
Ironwood Pharmaceuticals, Inc2$40
Dexcom, Inc.1$36
Sanofi Pasteur Inc.2$31
Arbor Pharmaceuticals, Inc.2$30
Alfasigma USA, Inc.1$28
Sunovion Pharmaceuticals Inc.2$27
Vanda Pharmaceuticals Inc.1$26
Inspire Medical Systems, Inc.1$23
Electromed, Inc.1$23
Cequr Corporation1$22
Radius Health, Inc.1$22
Fresenius Kabi USA, LLC1$21
GE HealthCare1$20
Genentech USA, Inc.1$20
Medtronic1$19
Biohaven Pharmaceuticals, Inc.1$18
Shire North American Group Inc1$18
Seqirus USA Inc1$17
Hologic Sales And Service, LLC1$14
Azurity Pharmaceuticals, Inc.1$14
Eisai Inc.1$14
Acerus Pharmaceuticals Corporation1$13
Hikma Pharmaceuticals USA1$12

How this compares

$14,217 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$137,476
Medicare patients
501
Services billed
3,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →